vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and NATIONAL FUEL GAS CO (NFG). Click either name above to swap in a different company.
NATIONAL FUEL GAS CO is the larger business by last-quarter revenue ($425.9M vs $339.0M, roughly 1.3× HAEMONETICS CORP). NATIONAL FUEL GAS CO runs the higher net margin — 35.7% vs 13.2%, a 22.5% gap on every dollar of revenue. On growth, NATIONAL FUEL GAS CO posted the faster year-over-year revenue change (1.7% vs -2.7%). Over the past eight quarters, NATIONAL FUEL GAS CO's revenue compounded faster (12.1% CAGR vs 0.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
National Fuel Gas Company is a diversified energy company with $6.2 billion in assets distributed among the following five operating segments: Exploration and Production, Pipeline and Storage, Gathering, Utility, and Energy Marketing. National Fuel Gas was incorporated in 1902 and is based in Williamsville, New York.
HAE vs NFG — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $425.9M |
| Net Profit | $44.7M | $152.0M |
| Gross Margin | 59.7% | — |
| Operating Margin | 19.9% | 81.5% |
| Net Margin | 13.2% | 35.7% |
| Revenue YoY | -2.7% | 1.7% |
| Net Profit YoY | 19.3% | — |
| EPS (diluted) | $0.95 | $1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.9M | ||
| Q4 25 | $339.0M | $637.9M | ||
| Q3 25 | $327.3M | $443.1M | ||
| Q2 25 | $321.4M | $527.4M | ||
| Q1 25 | $330.6M | $734.8M | ||
| Q4 24 | $348.5M | $513.8M | ||
| Q3 24 | $345.5M | $310.0M | ||
| Q2 24 | $336.2M | $338.6M |
| Q1 26 | — | $152.0M | ||
| Q4 25 | $44.7M | $181.6M | ||
| Q3 25 | $38.7M | $107.3M | ||
| Q2 25 | $34.0M | $149.8M | ||
| Q1 25 | $58.0M | $216.4M | ||
| Q4 24 | $37.5M | $45.0M | ||
| Q3 24 | $33.8M | $-167.6M | ||
| Q2 24 | $38.4M | $-54.2M |
| Q1 26 | — | — | ||
| Q4 25 | 59.7% | 86.6% | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | 94.7% | ||
| Q1 25 | 58.4% | 81.6% | ||
| Q4 24 | 55.5% | 87.3% | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | 98.5% |
| Q1 26 | — | 81.5% | ||
| Q4 25 | 19.9% | 43.3% | ||
| Q3 25 | 17.9% | 40.6% | ||
| Q2 25 | 16.8% | 43.7% | ||
| Q1 25 | 21.6% | 43.2% | ||
| Q4 24 | 16.9% | 16.8% | ||
| Q3 24 | 15.0% | -63.4% | ||
| Q2 24 | 11.8% | -15.2% |
| Q1 26 | — | 35.7% | ||
| Q4 25 | 13.2% | 28.5% | ||
| Q3 25 | 11.8% | 24.2% | ||
| Q2 25 | 10.6% | 28.4% | ||
| Q1 25 | 17.5% | 29.4% | ||
| Q4 24 | 10.8% | 8.8% | ||
| Q3 24 | 9.8% | -54.1% | ||
| Q2 24 | 11.4% | -16.0% |
| Q1 26 | — | $1.59 | ||
| Q4 25 | $0.95 | $1.98 | ||
| Q3 25 | $0.81 | $1.18 | ||
| Q2 25 | $0.70 | $1.64 | ||
| Q1 25 | $1.17 | $2.37 | ||
| Q4 24 | $0.74 | $0.49 | ||
| Q3 24 | $0.66 | $-1.81 | ||
| Q2 24 | $0.74 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | — |
| Total DebtLower is stronger | $1.2B | $300.0M |
| Stockholders' EquityBook value | $911.5M | — |
| Total Assets | $2.5B | $9.1B |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $363.4M | $271.4M | ||
| Q3 25 | $296.4M | $43.2M | ||
| Q2 25 | $292.9M | $39.3M | ||
| Q1 25 | $306.8M | $40.0M | ||
| Q4 24 | $320.8M | $48.7M | ||
| Q3 24 | $299.3M | $38.2M | ||
| Q2 24 | $344.4M | $81.4M |
| Q1 26 | — | $300.0M | ||
| Q4 25 | $1.2B | $2.7B | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.2B | $2.7B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | $911.5M | $3.6B | ||
| Q3 25 | $849.2M | $3.1B | ||
| Q2 25 | $882.3M | $3.0B | ||
| Q1 25 | $820.8M | $2.8B | ||
| Q4 24 | $906.9M | $-76.2M | ||
| Q3 24 | $878.9M | $-15.5M | ||
| Q2 24 | $905.4M | $5.0M |
| Q1 26 | — | $9.1B | ||
| Q4 25 | $2.5B | $9.2B | ||
| Q3 25 | $2.4B | $8.7B | ||
| Q2 25 | $2.5B | $8.4B | ||
| Q1 25 | $2.5B | $8.5B | ||
| Q4 24 | $2.5B | $8.3B | ||
| Q3 24 | $2.5B | $8.3B | ||
| Q2 24 | $2.5B | $8.5B |
| Q1 26 | — | — | ||
| Q4 25 | 1.34× | 0.75× | ||
| Q3 25 | 1.44× | 0.87× | ||
| Q2 25 | 1.39× | 0.90× | ||
| Q1 25 | 1.49× | 0.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 532.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | $657.3M |
| Free Cash FlowOCF − Capex | $87.2M | — |
| FCF MarginFCF / Revenue | 25.7% | — |
| Capex IntensityCapex / Revenue | 1.9% | 117.0% |
| Cash ConversionOCF / Net Profit | 2.09× | 4.32× |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $657.3M | ||
| Q4 25 | $93.6M | $274.9M | ||
| Q3 25 | $111.3M | $237.8M | ||
| Q2 25 | $17.4M | $388.4M | ||
| Q1 25 | $116.6M | $253.8M | ||
| Q4 24 | $43.8M | $220.1M | ||
| Q3 24 | $48.8M | $197.9M | ||
| Q2 24 | $-27.4M | $281.8M |
| Q1 26 | — | — | ||
| Q4 25 | $87.2M | $-2.7M | ||
| Q3 25 | $106.3M | $-47.8M | ||
| Q2 25 | $13.6M | $195.3M | ||
| Q1 25 | $100.9M | $59.9M | ||
| Q4 24 | $35.2M | $-20.3M | ||
| Q3 24 | $39.4M | $-49.1M | ||
| Q2 24 | $-33.1M | $79.5M |
| Q1 26 | — | — | ||
| Q4 25 | 25.7% | -0.4% | ||
| Q3 25 | 32.5% | -10.8% | ||
| Q2 25 | 4.2% | 37.0% | ||
| Q1 25 | 30.5% | 8.2% | ||
| Q4 24 | 10.1% | -4.0% | ||
| Q3 24 | 11.4% | -15.8% | ||
| Q2 24 | -9.8% | 23.5% |
| Q1 26 | — | 117.0% | ||
| Q4 25 | 1.9% | 43.5% | ||
| Q3 25 | 1.5% | 64.4% | ||
| Q2 25 | 1.2% | 36.6% | ||
| Q1 25 | 4.7% | 26.4% | ||
| Q4 24 | 2.5% | 46.8% | ||
| Q3 24 | 2.7% | 79.7% | ||
| Q2 24 | 1.7% | 59.7% |
| Q1 26 | — | 4.32× | ||
| Q4 25 | 2.09× | 1.51× | ||
| Q3 25 | 2.88× | 2.21× | ||
| Q2 25 | 0.51× | 2.59× | ||
| Q1 25 | 2.01× | 1.17× | ||
| Q4 24 | 1.17× | 4.89× | ||
| Q3 24 | 1.44× | — | ||
| Q2 24 | -0.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
NFG
| Revenues from External Customers | $425.8M | 100% |
| Intersegment Revenues | $126.0K | 0% |
